KR102576930B1 - 제2철 말톨의 결정질 형태 - Google Patents

제2철 말톨의 결정질 형태 Download PDF

Info

Publication number
KR102576930B1
KR102576930B1 KR1020167024732A KR20167024732A KR102576930B1 KR 102576930 B1 KR102576930 B1 KR 102576930B1 KR 1020167024732 A KR1020167024732 A KR 1020167024732A KR 20167024732 A KR20167024732 A KR 20167024732A KR 102576930 B1 KR102576930 B1 KR 102576930B1
Authority
KR
South Korea
Prior art keywords
polymorph
type
maltol
ferric
polymorphs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167024732A
Other languages
English (en)
Korean (ko)
Other versions
KR20170071446A (ko
Inventor
데이비드 폴 차일즈
Original Assignee
실드 티엑스 (유케이) 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52103522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102576930(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 실드 티엑스 (유케이) 리미티드 filed Critical 실드 티엑스 (유케이) 리미티드
Publication of KR20170071446A publication Critical patent/KR20170071446A/ko
Application granted granted Critical
Publication of KR102576930B1 publication Critical patent/KR102576930B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
KR1020167024732A 2014-10-28 2015-10-23 제2철 말톨의 결정질 형태 Active KR102576930B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1419174.6A GB2531742B (en) 2014-10-28 2014-10-28 Polymorphs of ferric maltol
GB1419174.6 2014-10-28
PCT/EP2015/074653 WO2016066555A1 (en) 2014-10-28 2015-10-23 Crystalline forms of ferric maltol

Publications (2)

Publication Number Publication Date
KR20170071446A KR20170071446A (ko) 2017-06-23
KR102576930B1 true KR102576930B1 (ko) 2023-09-12

Family

ID=52103522

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167024732A Active KR102576930B1 (ko) 2014-10-28 2015-10-23 제2철 말톨의 결정질 형태

Country Status (18)

Country Link
US (1) US9802973B2 (enExample)
EP (1) EP3160951B1 (enExample)
JP (2) JP6404358B2 (enExample)
KR (1) KR102576930B1 (enExample)
CN (1) CN107001310B (enExample)
AU (1) AU2015340825B2 (enExample)
CA (1) CA2944210C (enExample)
CL (1) CL2017001030A1 (enExample)
EA (1) EA033323B1 (enExample)
ES (1) ES2661944T3 (enExample)
GB (1) GB2531742B (enExample)
IL (1) IL251863A0 (enExample)
MX (1) MX370730B (enExample)
PL (1) PL3160951T3 (enExample)
SA (1) SA517381406B1 (enExample)
SG (1) SG11201702639RA (enExample)
WO (1) WO2016066555A1 (enExample)
ZA (1) ZA201702136B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2531742B (en) 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol
CN112574158B (zh) * 2020-12-29 2022-08-02 南京百泽医药科技有限公司 一种麦芽酚铁晶型ii及其制备方法
IT202100018578A1 (it) 2021-07-14 2023-01-14 Indena Spa Dispersione amorfa di maltolo ferrico e relativo processo di preparazione
AU2022349859A1 (en) * 2021-09-21 2024-05-02 Apicore Pharmaceuticals Private Limited An improved process for the preparation of ferric maltol
CN119638661B (zh) * 2024-12-09 2025-11-14 金陵药业股份有限公司 一种麦芽酚铁-槲皮素共晶及其制备方法
CN119638662B (zh) * 2024-12-09 2025-11-14 金陵药业股份有限公司 一种麦芽酚铁-草酸共晶及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097627A1 (en) 2002-05-18 2003-11-27 Vitra Pharmaceuticals Limited Method of forming iron hydroxypyrone compounds
WO2014165607A2 (en) 2013-04-02 2014-10-09 Stealth Peptides International, Inc. Aromatic-cationic peptide formulations, compositions and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE37534E1 (en) 1982-10-22 2002-01-29 Btg International Limited Pharmaceutical compositions
EP0107458B1 (en) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
GB8410290D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB201101370D0 (en) * 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
GB2531742B (en) 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097627A1 (en) 2002-05-18 2003-11-27 Vitra Pharmaceuticals Limited Method of forming iron hydroxypyrone compounds
WO2014165607A2 (en) 2013-04-02 2014-10-09 Stealth Peptides International, Inc. Aromatic-cationic peptide formulations, compositions and methods of use

Also Published As

Publication number Publication date
WO2016066555A1 (en) 2016-05-06
JP2018197268A (ja) 2018-12-13
EA033323B1 (ru) 2019-09-30
EA201790667A1 (ru) 2017-08-31
CL2017001030A1 (es) 2018-01-19
BR112017008903A2 (pt) 2017-12-19
KR20170071446A (ko) 2017-06-23
GB2531742A (en) 2016-05-04
EP3160951A1 (en) 2017-05-03
GB2531742B (en) 2016-10-05
MX370730B (es) 2019-12-20
AU2015340825B2 (en) 2016-11-24
MX2017005413A (es) 2017-10-04
US20170260222A1 (en) 2017-09-14
CN107001310A (zh) 2017-08-01
JP6404358B2 (ja) 2018-10-10
AU2015340825A1 (en) 2016-08-25
GB201419174D0 (en) 2014-12-10
JP6678711B2 (ja) 2020-04-08
US9802973B2 (en) 2017-10-31
CA2944210C (en) 2017-06-20
ZA201702136B (en) 2018-11-28
CA2944210A1 (en) 2016-05-06
SA517381406B1 (ar) 2021-03-15
PL3160951T3 (pl) 2018-07-31
ES2661944T3 (es) 2018-04-04
SG11201702639RA (en) 2017-05-30
IL251863A0 (en) 2017-06-29
EP3160951B1 (en) 2017-12-06
CN107001310B (zh) 2020-05-22
JP2017535510A (ja) 2017-11-30

Similar Documents

Publication Publication Date Title
KR102576930B1 (ko) 제2철 말톨의 결정질 형태
JP6206689B2 (ja) ５−アミノ−２，３−ジヒドロフタラジン−１，４−ジオンナトリウム塩の結晶形ｉまたはｉｉを含有する医薬製剤
JP2007302658A (ja) イマチニブメシレートの多形フォーム及び新規結晶フォーム及び非晶フォーム並びにフォームαの調製方法
CN105189513A (zh) 葡萄糖醇，1-脱氧-1-(甲胺基)-,1-(6-氨基-3,5-二氟吡啶-2-基)-8-氯-6-氟-1,4-二氢-7-(3-羟基氮杂环丁烷-l-基)-4-氧-3-喹啉羧酸盐的结晶形态
WO2021139797A1 (zh) 恩曲替尼晶型及其制备方法
KR102672632B1 (ko) S1p1 수용체 작용제의 부가 염 및 이의 결정 형태 및 약제학적 조성물
CN113559102B (zh) 包括trh类似物和丙基辛酸的组合的组合物和丙基辛酸的药学上可接受的盐
HK1233619B (en) Crystalline forms of ferric maltol
HK1233619A1 (en) Crystalline forms of ferric maltol
CN105308043B (zh) 丙型肝炎药物的晶型及其制备方法、其药物组合物和用途
BR112017008903B1 (pt) Formas cristalinas de maltol férrico
WO2015109925A1 (zh) 丙型肝炎药物的晶型及其制备方法、其药物组合物和用途
WO2022143897A1 (zh) A-失碳-5α雄甾烷化合物的多晶型物
WO2019070698A1 (en) Novel forms of ibrutinib
HK1223929B (zh) 5-氨基-2，3-二氢-(2，3-二氮杂萘)-1，4-二酮钠盐的晶型
NZ719970A (en) Solid forms of { [5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid, compositions, and uses thereof
NZ719970B2 (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
NZ759132B2 (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20160907

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20201022

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220809

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230222

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20230802

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20230906

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20230907

End annual number: 3

Start annual number: 1

PG1601 Publication of registration